Literature DB >> 32854916

Erdafitinib Overcomes FGFR3-TACC3-Mediated Resistance to Osimertinib.

Eric B Haura1, J Kevin Hicks2, Theresa A Boyle3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32854916     DOI： 10.1016/j.jtho.2019.12.132

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  4 in total

Review 1.  Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management.

Authors:  Alissa J Cooper; Lecia V Sequist; Jessica J Lin
Journal:  Nat Rev Clin Oncol       Date:  2022-05-09       Impact factor: 65.011

2.  FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).

Authors:  Ari Raphael; Elizabeth Dudnik; Dov Hershkovitz; Suyog Jain; Steve Olsen; Lior Soussan-Gutman; Taly Ben-Shitrit; Addie Dvir; Hovav Nechushtan; Nir Peled; Amir Onn; Abed Agbarya
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

3.  Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors.

Authors:  Yoshihisa Kobayashi; Geoffrey R Oxnard; Elizabeth F Cohen; Navin R Mahadevan; Joao V Alessi; Yin P Hung; Arrien A Bertram; David E Heppner; Mauricio F Ribeiro; Karina P Sacardo; Rodrigo Saddi; Mariana P Macedo; Rafael B Blasco; Jiaqi Li; Kari J Kurppa; Tom Nguyen; Emma Voligny; Guruprasad Ananda; Roberto Chiarle; Artur Katz; Michael Y Tolstorukov; Lynette M Sholl; Pasi A Jänne
Journal:  Nat Commun       Date:  2022-09-24       Impact factor: 17.694

Review 4.  Integrating Somatic and Germline Next-Generation Sequencing Into Routine Clinical Oncology Practice.

Authors:  J Kevin Hicks; Rachel Howard; Phillip Reisman; Jacob J Adashek; Karen K Fields; Jhanelle E Gray; Bryan McIver; Kelly McKee; Mandy F O'Leary; Randa M Perkins; Edmondo Robinson; Ankita Tandon; Jamie K Teer; Joseph Markowitz; Dana E Rollison
Journal:  JCO Precis Oncol       Date:  2021-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.